Tate & Lyle

History

Year	Detail
1921	Henry Tate & Sons and Abram Lyle & Sons merged, refining together around 50% of the UK’s sugar.
1965	Tate & Lyle acquired United Molasses and expanded its operations in the sugar and syrup industries. This acquisition helped Tate & Lyle strengthen its position in the global market for food ingredients.
1976	Sucralose, the no-calorie sweetener, was discovered by Tate & Lyle in partnership with researchers at Queen Elizabeth College, University of London. Tate & Lyle developed the product in collaboration with McNeil Nutritionals LLC (a Johnson & Johnson company) to create SPLENDA Sucralose.
1983	Tate & Lyle invested in the Portuguese sugar producer Alcântara as part of its strategy to expand its operations in Europe and strengthen its presence in the sugar market.
1988	The company acquired 90% of AE Staley Manufacturing Co., which enhanced its presence in the U.S. sweetener market. Additionally, the company increased its stake in Amylum to 63%, further consolidating its position in the European starch and sweeteners sector.
1998	Tate & Lyle acquired Haarmann & Reimer, a subsidiary of Bayer AG. This acquisition strengthened Tate & Lyle's capabilities in the flavors and sweeteners market, enabling the company to broaden its product range and enhance its competitive position globally.
2004	The company partnered with DuPont to produce Bio-PDO (1,3-propanediol), a bio-based material derived from renewable sources. This collaboration aimed to develop sustainable solutions for producing chemicals and materials.
2005	The company acquired Cesalpinia Foods, expanding its portfolio in the specialty ingredients market. This acquisition allowed Tate & Lyle to expand its offerings and strengthen its position in the food sector, particularly in functional ingredients.
2006	Tate & Lyle acquired Continental Custom Ingredients (CCI), a US specialty food ingredients company founded in 1975. CCI became a recognized leader in dairy stabilizers and emulsifier systems, working closely with customers to develop ingredient systems for the North American market.
2007	DuPont Tate & Lyle Bio Products, LLC, an equally-owned joint venture of DuPont and Tate & Lyle, opened its new facility to produce 1,3-propanediol (Bio-PDO) from renewable resources.
2009	G. C. HAHN & Co. joined Cesalpinia Food and Tate & Lyle’s stabilizer businesses in South Africa, Australia, and New Zealand, already trading under the Tate & Lyle name.
2010	The company sold its sugar business (EU operations), including Lyle’s Golden Syrup brand, to American Sugar Refining, Inc (ASR), ending its long association with refined sugar production.
2013	Tate & Lyle bought Biovelop, a Swedish manufacturer of oat beta-glucan. Now known as Tate & Lyle Oat Ingredients, the business uses a unique chemical-free technology to manufacture high-quality oat beta-glucan, a soluble fiber with widely approved health claims.
2014	The company acquired Winway Biotechnology Co Ltd, China. This became the company's third polydextrose facility globally, in addition to existing lines in the Netherlands and the US.
2014	The company joint ventures with a Brazilian stabilizer business, Gemacom Tech Indústria e Comércio S.A. The joint venture is called Tate & Lyle Gemacom Tech.
2020	The company acquired Sweet Green Fields, a leading supplier of stevia and other natural sweeteners. This acquisition aimed to enhance Tate & Lyle's capabilities in the growing plant-based and low-calorie sweeteners market, aligning with consumer demand for healthier options.
2022	The company acquired Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a leading prebiotic dietary fiber business in China. This acquisition significantly strengthens the company's fortification platform and position as a global player in dietary fibers.
2023	The company established a new Customer Innovation and Collaboration Centre in Jakarta, Indonesia. This expansion is aimed at growing the company in the Asia Pacific region, specifically in Indonesia.